Ignite Creation Date:
2025-12-25 @ 1:43 AM
Ignite Modification Date:
2026-01-01 @ 3:55 PM
Study NCT ID:
NCT04220294
Status:
COMPLETED
Last Update Posted:
2023-02-21
First Post:
2020-01-05
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Subcutaneous Continuous Versus Interrupted Sutures During Cesarean Section.
Sponsor:
Rambam Health Care Campus
Organization:
Study Overview
Official Title:
Surgical Site Infection Rate After Subcutaneous Continuous Versus Interrupted Sutures During Cesarean Section.
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
A comparison of the rate of surgical site infections after cesarean section depending on the type of suture used for subcutaneous closure-continuous versus interrupted.
Detailed Description:
Patients at term that are candidates for elective cesarean section will receive an explanation regarding the study and sign informed consent. Patients will then be divided randomly to one of 2 treatment groups based on the type of subcutaneous tissue closure:
1. Interrupted sutures.
2. Continuous sutures. Information regarding medical and obstetric history will be collected for each patient.
1. Interrupted sutures.
2. Continuous sutures. Information regarding medical and obstetric history will be collected for each patient.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: